Wann muss man an eine chronisch-entzündliche Darmerkrankung bei Kindern und Jugendlichen denken?

I. J. Broekaert; M. J. Lentze

doi:10.1055/s-0037-1616268

Kinder- und Jugendmedizin, Table of Contents

Kinder- und Jugendmedizin 2016; 16(01): 7-10
DOI: 10.1055/s-0037-1616268

Gastroenterologie

Schattauer GmbH

Wann muss man an eine chronisch-entzündliche Darmerkrankung bei Kindern und Jugendlichen denken?

Warnsymptome, Basisdiagnostik und weiterführende Untersuchungen bei abdominellen SymptomenWhen to think of inflammatory bowel disease in children and adolescents — red flag signs, basic and advanced diagnostic investigations of abdominal symptoms

I. J. Broekaert

¹Universitätskinderklinik Köln;

,

M. J. Lentze

²Universitätskinderklinik Bonn

› Author Affiliations

Abstract

Zusammenfassung

Die Inzidenz der chronisch-entzündlichen Darmerkrankungen (CED), v. a. des Morbus Crohn, im Kindesalter nimmt zu. Zwischen 20 und 30 % der CED-Patienten befinden sich im Kindes- oder Jugendalter.

Typisch für die Colitis ulcerosa ist eine blutige Diarrhö. Beim M. Crohn zeigen sich häufig unspezifische Bauchschmerzen, Diarrhö, Anämie, Fieber, Gewichtsverlust und Wachstumsverzögerung. Wachstumsverzögerungen durch eine verzögerte Diagnose oder unzureichenden Behandlung einer CED sind eine besondere Komplikation im Kindes- und Jugendalter. Weitere extraintestinale Manifestationen sind Müdigkeit, Anorexie sowie Gelenk-, Haut-, Augen-, Leber-, Gallengangs- und Pankreasbeteiligung. Nach dem Ausschluss von gastrointestinalen Infektionen helfen Entzündungsmarker im Blut sowie Calprotectin und Laktoferrin im Stuhl für die Diagnose. Für die endgültige Diagnose und Klassifizierung sind die Ileokoloskopie und Ösophagogastroduodenoskopie notwendig. Weitere Bildgebung (z. B. MRT, Videokapselendoskopie) wird empfohlen.

Summary

The incidence of inflammatory bowel diseases (IBD), especially Crohn’s disease, in children and adolescents is on the rise. Between 20 and 30 % of IBD patients are children or adolescents.

Bloody diarrhea is the most common presenting symptom in ulcerative colitis. Crohn’s disease may present with vague abdominal pain, diarrhea, anemia, fever, weight loss, and growth retardation. Growth retardation is a unique complication due to delayed diagnosis of or uncontrolled inflammation in IBD in children and adolescents. Further extraintestinal manifestations are fatigue, anorexia, and joint, skin, eye, hepatobiliary and pancreatic manifestations.

After exclusion of gastrointestinal infections blood and fecal inflammatory markers are helpful for the diagnosis. The final diagnosis and classification relies on ileocolonoscopy and esophagogastroduodenscopy. Further imaging (such as MRI and video capsule endoscopy) is recommended.

Schlüsselwörter

Chronisch-entzündliche Darmerkrankung - Kinder - Jugendliche - Symptome - Diagnostik

Keywords

Inflammatory bowel disease - children - adolescents - symptoms - diagnostics

Full Text

References

Literatur
1 Adams DJ, Colombo JM. An Unusual Presentation of Inflammatory Bowel Disease. Mil Med 2012; 177: 240-242.
2 Auvin S, Molinié F, Gower-Rousseau C. et al. Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population-Based Study in Northern France (1988–1999). J Pediatr Gastroenterol Nutr 2005; 41: 49-55.
3 Benchimol EI, Fortinsky KJ, Gozdyra P. et al. Epidemiology of Pediatric Inflammatory Bowel Disease: a Systematic Review of International Trends. Inflamm Bowel Dis 2011; 17: 423-439.
4 Buderus S, Scholz D, Behrens R. et al. Inflammatory Bowel Disease in Pediatric Patients. Characteristics of Newly Diagnosed Patients From the CEDATA-GPGE Registry. Dtsch Arztebl Int 2015; 112: 121-127.
5 Cardile S, Romano C. Current Issues in Pediatric Inflammatory Bowel Disease-Associated Arthropathies. World J Gastroenterol 2014; 20: 45-52.
6 Day AS, Lemberg DA, Gearry RB. Inflammatory Bowel Disease in Australasian Children and Adolescents. Gastroenterol Res Pract 2014; 2014: 703890.
7 de Bie CI, Buderus S, Sandhu BK. et al. Diagnostic Workup of Paediatric Patients with Inflammatory Bowel Disease in Europe: Results of a 5-Year Audit of the EUROKIDS Registry. J Pediatr Gastroenterol Nutr 2012; 54: 374-380.
8 Dubinsky M. What Is the Role of Serological Markers in IBD? Pediatric and Adult Data. Dig Dis 2009; 27: 259-268.
9 Ezri J, Marques-Vidal P, Nydegger A. Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease. Digestion 2012; 85: 308-319.
10 Feakins RM. Ulcerative Colitis or Crohn’s Disease? Pitfalls and Problems. Histopathology 2014; 64: 317-335.
11 Henderson P, Anderson NH, Wilson DC. The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: a Systematic Review and Meta-Analysis. Am J Gastroenterol 2014; 109: 637-645.
12 IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory Bowel Disease in Children and Adolescents: Recommendations for Diagnosis – The Porto Criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7.
13 Levine A, Koletzko S, Turner D. et al. ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents. J Pediatr Gastroenterol Nutr 2014; 58: 795-806.
14 Mentzel HJ, Reinsch S, Kurzai M, Stenzel M. Magnetic Resonance Imaging in Children and Adolescents with Chronic Inflammatory Bowel Disease. World J Gastroenterol 2014; 20: 1180-1191.
15 Molodecky NA, Soon IS, Rabi DM. et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology 2012; 142: 46-54.
16 Timmer A, Behrens R, Buderus S. et al. Childhood Onset Inflammatory Bowel Disease: Predictors of Delayed Diagnosis from the CEDATA German-Language Pediatric Inflammatory Bowel Disease Registry. J Pediatr. 2011; 158: 467-473.
17 Van Limbergen J, Russell RK, Drummond HE. et al. Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease. Gastroenterology 2008; 135: 1114-1122.
18 Waugh N, Cummins E, Royle P. et al. Faecal Calprotectin Testing for Differentiating Amongst Inflammatory and Non-Inflammatory Bowel Diseases: Systematic Review and Economic Evaluation. Health Technol Assess 2013; 17: xv-xix 1–211.